Skip to main content

M Miller

First name:
M
Last name:
Miller
Poonai, N., Mehrotra, S., Mamdani, M., Patmanidis, A., Miller, M., Sukhera, J., & Doan, Q. (2018). The association of exposure to suicide-related Internet content and emergency department visits in children: A population-based time series analysis. Canadian Journal Of Public Health = Revue Canadienne De Sante Publique, 108(5-6), e462-e467. (Original work published 2018)
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., et al. (2019). Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. The New England Journal Of Medicine, 380(1), 11-22. https://doi.org/10.1056/NEJMoa1812792 (Original work published 2019)
Ridker, P. M., Revkin, J., Amarenco, P., Brunell, R., Curto, M., Civeira, F., et al. (2017). Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. The New England Journal Of Medicine, 376(16), 1527-1539. https://doi.org/10.1056/NEJMoa1701488 (Original work published 2017)
Peck, K., Towne, T., Wierenga, C. E., Hill, L., Eisler, I., Brown, T., et al. (2021). Temperament-based treatment for young adults with eating disorders: acceptability and initial efficacy of an intensive, multi-family, parent-involved treatment. Journal Of Eating Disorders, 9(1), 110. https://doi.org/10.1186/s40337-021-00465-x (Original work published 2021)
Verma, S., Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., et al. (2021). Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG. Circulation, 144(23), 1845-1855. https://doi.org/10.1161/CIRCULATIONAHA.121.056290 (Original work published 2021)